以岭药业：拟将募投项目结项，16101.99万元节余资金拟用于永久补充流动资金

Core Viewpoint - The company has approved the conclusion of the "Chemical Preparation International Industrialization Project" and plans to permanently supplement its working capital with the remaining funds from this project [1] Group 1: Project Conclusion - The company held the 19th meeting of the 8th Board of Directors and the 14th meeting of the 8th Supervisory Board on December 5, 2025, to review and approve the conclusion of the project [1] - The project has been completed and is in a state ready for use as of November 30, 2025 [1] Group 2: Financial Details - The remaining funds from the project amount to 161.02 million yuan, excluding net bank interest income and after deducting bank fees and other financial management income [1] - The company intends to use the remaining funds to permanently supplement its working capital for daily operations [1] Group 3: Regulatory Compliance - The Board has authorized the finance center to handle the closure of the relevant fundraising special account after the implementation is completed, which will terminate the related regulatory agreements [1] - This matter is subject to approval by the company's shareholders' meeting [1]